Register Login
Register to leave comments
  • News bot Aug. 17, 2026, 11:18 a.m.

    📋 ADIAL PHARMACEUTICALS, INC. (ADIL) - Clinical Trial Update

    Filing Date: 2026-08-17

    Accepted: 2026-08-17 07:17:57

    Event Type: Clinical Trial Update

    Event Details:

    ADIAL PHARMACEUTICALS, INC. (ADIL) Announces Clinical Trial Update ADIAL PHARMACEUTICALS, INC. (ADIL) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: results, agonist
    • Collaboration: establishes a new strategic focus for Company
      • planned for the first half of 2027

    🔬 Clinical Development Pipeline (ADIAL PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Brief Psychological Counseling Other Phase PHASE3 Alcohol Use Disorder ClinicalTrials.gov
    Companion Diagnostic for Genetic Testing Other Phase PHASE3 Alcohol Use Disorder ClinicalTrials.gov
    Matching placebo Other Phase PHASE3 Alcohol Use Disorder ClinicalTrials.gov
    AD04 (ondansetron) Other Phase PHASE3 Alcohol Use Disorder ClinicalTrials.gov
    ADS-8902 DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    Oseltamivir Phosphate DRUG Phase PHASE2 Influenza ClinicalTrials.gov
    Placebo OTHER Phase PHASE2 Walking Impairment ClinicalTrials.gov
    ADS-5102 DRUG Phase PHASE2 Walking Impairment ClinicalTrials.gov
    ADS-5102 (extended release amantadine HCl) DRUG Phase PHASE2 Dyskinesia ClinicalTrials.gov
    ADS-5102, 274 mg DRUG Phase PHASE3 Multiple Sclerosis ClinicalTrials.gov
    320mg Amantadine HCl ER tablets DRUG Phase PHASE3 Parkinson's Disease ClinicalTrials.gov
    Placebo tablets DRUG Phase PHASE3 Parkinson's Disease ClinicalTrials.gov
    240mg Amantadine HCl ER tablets DRUG Phase PHASE3 Parkinson's Disease ClinicalTrials.gov
    amantadine HCl ER DRUG Phase PHASE3 Parkinson's Disease ClinicalTrials.gov
    GOCOVRI DRUG Phase PHASE4 Parkinson Disease ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ADIAL PHARMACEUTICALS, INC.
    • Ticker Symbol: ADIL

Search

News categories